SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-012056
Filing Date
2020-05-14
Accepted
2020-05-13 18:10:23
Documents
51
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0320_inmunebio.htm 10-Q 327879
2 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER f10q0320ex31-1_inmunebio.htm EX-31.1 11116
3 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CHIEF FINANCIAL OFFICER f10q0320ex31-2_inmunebio.htm EX-31.2 10613
4 SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER f10q0320ex32-1_inmunebio.htm EX-32.1 4323
5 SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER f10q0320ex32-2_inmunebio.htm EX-32.2 4385
  Complete submission text file 0001213900-20-012056.txt   2416418

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE inmb-20200331.xml EX-101.INS 292723
7 XBRL SCHEMA FILE inmb-20200331.xsd EX-101.SCH 43499
8 XBRL CALCULATION FILE inmb-20200331_cal.xml EX-101.CAL 36448
9 XBRL DEFINITION FILE inmb-20200331_def.xml EX-101.DEF 154217
10 XBRL LABEL FILE inmb-20200331_lab.xml EX-101.LAB 288148
11 XBRL PRESENTATION FILE inmb-20200331_pre.xml EX-101.PRE 224130
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 20874677
SIC: 2836 Biological Products, (No Diagnostic Substances)